Atovaquone 13C6

[13C6]-Atovaquone is a stable isotope-labeled version of the antimalarial drug atovaquone. Atovaquone is a hydroxynaphthoquinone derivative that is used in the treatment of malaria and other protozoal infections. The addition of six carbon-13 isotopes to the molecule allows for easier detection and measurement in biological samples using mass spectrometry. [13C6]-Atovaquone is commonly used in pharmacokinetic and metabolic studies to understand the absorption, distribution, metabolism, and excretion of atovaquone in the human body. It is administered orally or intravenously, and its distribution and metabolism can be tracked through the use of mass spectrometry. In addition to its use in research, [13C6]-Atovaquone may have potential clinical applications. The labeled drug may help to optimize dosing regimens and improve patient outcomes by providing a better understanding of atovaquone's pharmacokinetic properties. In terms of chemical information, [13C6]-Atovaquone has a molecular formula of C22H16D6Cl3O3, and a molecular weight of 516.83 g/mol. It is a yellow crystalline powder that is sparingly soluble in water. The labeled drug is stable under normal conditions and should be stored at -20°C.